RENAULT MASTER E-TECH ELECTRIC HELPS CANCER RESEARCH UK RAISE FUNDS AND LOWER ITS LOCAL CARBON FOOTPRINT

• Cancer Research UK adds Renault Master E-Tech electric vans to its retail logistics fleet
• New vans support movement of donated stock between local shops and the charity’s Regional Distribution Centre in Fleet
• Vehicles selected after evaluation of whole-life costs, electric range, payload and driver feedback
• Each van is expected to cover up to 800 miles per week
• Multi-award-winning Renault Master E-Tech electric offers a WLTP range of up to 285 miles and is priced from £37,500 plus VAT after PiVG

Cancer Research UK has strengthened its retail logistics fleet with the Renault Master E-Tech electric, helping the charity keep donated stock moving between its Regional Distribution Centre in Fleet and its shop network while reducing local tailpipe emissions.

The new vans will be driven by Cancer Research UK’s full-time drivers and are expected to cover up to 800 miles per week. Each van has been equipped with racking, LED lighting and 360-degree parking sensors to help make light work of busy daily deliveries, while Cancer Research UK’s distinctive livery ensures they are instantly recognisable on the road.

The Renault Master E-Tech electric LM35 (LWB Medium Roof) panel van was selected following a comprehensive evaluation process, with Cancer Research UK assessing whole-life costs, electric range, payload and driver feedback. The charity already operates an all-Renault LCV fleet comprising a mix of panel vans, Luton low-floor vehicles, and a Renault Kangoo E-Tech electric.

Colin Jones, Senior Contracts Manager, Fleet & Travel at Cancer Research UK, said: “Every item we move through our retail network has the potential to help fund life-saving research, so having the right vehicles in place really matters. The Renault Master E-Tech electric gives our teams the space, range and usability they need to keep stock flowing from our Regional Distribution Centre into local shops, while helping us reduce local emissions from our operations.”

Seb Brechon, Head of LCV, Renault UK, said: “Cancer Research UK’s adoption of the Master E-Tech electric shows how electric vans can deliver in busy, real-world fleet operations where practicality, range and driver confidence all matter. With strong load-carrying capability, a highly usable working environment and up to 285 miles of WLTP range, the Master E-Tech electric is well suited to organisations that need their vehicles to perform every day. We’re pleased to support Cancer Research UK as it puts electric vans to work in a way that directly supports its fundraising activity.”

The multi-award-winning Renault Master continues to set the benchmark in the large van segment, combining enhanced payload capability with load spaces ranging from 11 to 20 cubic metres and a user-focused design created around everyday operator convenience.

The Master E-Tech electric’s 105kW/300Nm electric motor is paired with an 87kWh battery, delivering a WLTP range of up to 285 miles. DC fast charging can add up to 142 miles of range in just 30 minutes, giving operators the flexibility to charge overnight or make rapid top-ups during the working day.

For more information on the Renault Master E-Tech electric, which is priced from £37,500 plus VAT after PiVG, visit: https://business.renault.co.uk/master-range/master-panel-electric.html

END

ABOUT RENAULT
Renault is the world’s leading French car brand, building on over a century of innovation to develop voitures à vivre based on desirable design with useful, people-first technologies and electrified powertrains that make no compromises on driving pleasure. Designed as living spaces, Renault vehicles are made for everyday living. Having initiated on an in-depth transformation with the Renaulution plan, the brand is now beginning a new strategic cycle with futuREady, a plan to boost its competitive edge and deliver long-term performance, both in Europe and internationally. This ambition is based on desirable products and increased international momentum, as well as on a pragmatic two-pillar approach to electrification – 100 % hybrid and 100 % electric – in order to support the energy transition at any pace of progress.

ABOUT CANCER RESEARCH UK

• Cancer Research UK is the world’s leading cancer charity dedicated to saving and improving lives through research, influence and information. 
• Cancer Research UK’s pioneering work into the prevention, detection and treatment of cancer has helped save millions of lives.  
• Cancer Research UK has been at the heart of the progress that has already seen survival in the UK double over the past 50 years.  
• Cancer Research UK supports research into the prevention and treatment of cancer through the work of over 4,000 scientists, doctors and nurses. 
• Together with its partners and supporters, Cancer Research UK is working towards a world where everybody can live longer, better lives, free from the fear of cancer. 
• For further information about Cancer Research UK's work or to find out how to support the charity, please call 0300 123 1022 or visit cruk.org

For further information, please visit www.press.renault.co.uk or @RenaultUKPR or contact:

Jim Holder
Director of Communications
jim.holder@renault.co.uk – 07779 227930

Christian Tilbury
Press Relations Manager
christian.tilbury@renault.co.uk – 07759 122784